Risk factors for benign prostatic hyperplasia.

Curr Urol Rep. 2007 Jul;8(4):281-8.
Jacobsen SJ.

Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. jacobsen@mayo.edu

This review summarizes recent findings regarding risk factors for benign prostatic hyperplasia (BPH), including new data on hormonal factors, growth factors, comorbid conditions and lifestyle, diet, and exercise as they relate to BPH. In addition, it addresses the design and measurement issues that influence the inference that can be drawn from those studies. Most of the population-based studies on BPH have provided only modest insight into risk factors for BPH. The relationships with circulating levels of steroid hormones and growth factors are still unclear, whereas the association between sexual function and BPH is fairly consistent. Whether this represents a cause and effect relationship or is due to some unobserved confounding factor remains uncertain. There are few data on lifestyle factors that may be amenable to intervention. As future studies aim to address these issues, they should be carried out with rigorous methods, bypassing as many of the methodologic shortcomings of past studies as possible.

• Do lifestyle changes work for improving erectile dysfunction?
• Lifestyle management of erectile dysfunction: the role of cardiovascular and concomitant risk factors.
• Lower urinary tract symptoms in patients with erectile dysfunction: analysis of risk factors.
• Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study.
• Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction.